Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
Toso
Christian
C
Morel
Philippe
P
Bucher
Pascal
P
Mathe
Zoltan
Z
Demuylder-Mischler
Sandrine
S
Bosco
Domenico
D
Berney
Thierry
T
Oberholzer
José
J
Shapiro
James
J
Oberholzer
José
J
Philippe
Jacques
J
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000601:surgery*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage*; D016381:Islets of Langerhans Transplantation; D016030:Kidney Transplantation; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D007328:Insulin; D020123:Sirolimus; D016559:Tacrolimus